Last reviewed · How we verify
NCT03677739
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NA trial testing Informational Intervention in Clinical Stage 0 Cutaneous Melanoma AJCC v8 in 1,160 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2025
Quick facts
| Lead sponsor | Rutgers, The State University of New Jersey |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 1,160 |
| Start date | 3 June 2019 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Informational Intervention
- Informational Intervention
- Survey Administration
Conditions studied
- Clinical Stage 0 Cutaneous Melanoma AJCC v8 — all drugs for Clinical Stage 0 Cutaneous Melanoma AJCC v8 →
- Clinical Stage I Cutaneous Melanoma AJCC v8 — all drugs for Clinical Stage I Cutaneous Melanoma AJCC v8 →
- Clinical Stage IA Cutaneous Melanoma AJCC v8 — all drugs for Clinical Stage IA Cutaneous Melanoma AJCC v8 →
- Clinical Stage IB Cutaneous Melanoma AJCC v8 — all drugs for Clinical Stage IB Cutaneous Melanoma AJCC v8 →
Sponsor
Rutgers, The State University of New Jersey
Who can join
Adults 18 to 80, any sex, with Clinical Stage 0 Cutaneous Melanoma AJCC v8 or Clinical Stage I Cutaneous Melanoma AJCC v8. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial studies how well Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention works in improving skin examination in participants with melanoma and their families. Young Melanoma Family Facebook intervention or Healthy Lifestyle Facebook intervention may help improve total cutaneous examinations, skin self-examinations, and sun protection among first degree relatives of young onset participants and the participants themselves.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population.
Petkovic J, Duench S, Trawin J, Dewidar O, et al · · 2021 · cited 78× · PMID 34057201 · DOI 10.1002/14651858.cd012932.pub2 -
Facebook Intervention for Young-Onset Melanoma Survivors and Families: Protocol for a Randomized Controlled Trial.
Manne S, Pagoto S, Peterson S, Heckman C, et al · · 2023 · cited 4× · PMID 36692933 · DOI 10.2196/39640 -
Engagement in and correlates of total cutaneous exams and skin self-exams among young melanoma survivors and their family.
Manne SL, Kashy DA, Pagoto S, Peterson SK, et al · · 2025 · PMID 40684394 · DOI 10.1007/s10865-025-00589-4
Verify or expand the search:
- PubMed search for NCT03677739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Informational Intervention
Trials testing the same drug.
- NCT06977503 — Electrotherapy Stimulation Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers · NA · recruiting
- NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer · NA · not yet recruiting
- NCT06927947 — Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes · NA · recruiting
- NCT06568016 — A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemi · NA · recruiting
- NCT06639958 — A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home · NA · suspended
Other recruiting trials for Clinical Stage 0 Cutaneous Melanoma AJCC v8
Currently open trials in the same condition.
- NCT07258446 — PRAME Immunohistochemistry-Guided Slow Mohs Micrographic Surgery for the Treatment of Stage 0 to IIc Cutaneous Melanoma · NA · recruiting
- NCT03819296 — Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer · Phase 1 · recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
- NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
- NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
- NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
- NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
- NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03677739 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03677739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing